SCM
RMD icon

Suvretta Capital Management’s ResMed RMD Stock Holding History

Suvretta Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$537K Hold
2,390
– – 0.01% 82
2025
Q4 		$576K Hold
2,390
– – 0.01% 86
2025
Q3 		$654K Hold
2,390
– – 0.02% 87
2025
Q2 		$617K Hold
2,390
– – 0.02% 87
2025
Q1 		$535K Hold
2,390
– – 0.02% 94
2024
Q4 		$547K Hold
2,390
– – 0.02% 90
2024
Q3 		$583K Hold
2,390
– – 0.02% 92
2024
Q2 		$457K Hold
2,390
– – 0.02% 90
2024
Q1 		$473K Buy
+2,390
New +$438K 0.02% 95

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Suvretta Capital Management's RMD Position: Q1 2026 in Review

Suvretta Capital Management held its ResMed (RMD) position steady in Q1 2026 at 2,390 shares worth $537K. The position accounts for 0.01% of the portfolio, ranked #82.

Suvretta Capital Management first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $654K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Suvretta Capital Management held 2,390 shares of ResMed worth $537K as of Q1 2026.
  • Suvretta Capital Management left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.01% of Suvretta Capital Management's portfolio in Q1 2026, its #82 holding.
  • Suvretta Capital Management first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
  • Suvretta Capital Management's ResMed position peaked at $654K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.